Biopharmaceutical Expression Systems and Genetic Engineering Technology

BioPlan Associates, Inc.
November 1, 2008
415 Pages - SKU: DFAQ2174877
License type:
Comprehensive Review of Expression
Systems for Biopharmaceutical
Manufacturing

New biopharmaceutical expression systems are beginning to revolutionize the industry! Lower costs and efficiencies of newer expression systems are driving these changes. Our new study provides you all the information you need to begin the shift to increased productivity. Since the 1970s little has changed in the technologies used for commercial-scale biomanufacturing (E. coli, CHO cells, or S. cerevisiae as hosts). But that’s all beginning to change. This report tells you where, by whom, and how!

Coverage includes host cells/organisms, basic genetic engineering methods, recombinant constructs , organisms, vectors, promoters, selection and amplification methods, chaperones, and technologies that improve expression of glycoproteins and antibodies.

315 Data-packed pages
439 Monographs
286 Companies profiled
40 Multi-platform technologies
71 Bacteria and prokaryotes
42 Yeasts
28 Mammalian
Dozens of plants, insects, cell-free, human, chicken, hybridomas & more
Scores of vectors, promoters, selection & amplification methods, chaperones for commercial-scale biomanufacture
What You’ll Get

The single most informative source for commercial biomanufacturing expression systems and technologies.
Conduct further research: Contact technology licensing sources.
Find what fits: Large and small drug innovators, CMOs, biogenerics companies developing new licensing/income streams; innovators dreaming of starting a new company, will find opportunities.
Find good investments: Ample opportunities to get involved at the early stages of technology licensing.
Find technological advances: Ready for adoption, adaptation and development, opportunities for process improvements and profit.